MaxQ AI announces ISO 27001 certification

MaxQ AI has achieved ISO 27001 certification, meaning the Tel Aviv, Israel-based company fully complies with the internationally recognized information security standard.

The standard provides key requirements related to information security management systems, ensuring that sensitive data remains secure at all times. It was designed to work for small, medium and large businesses from any industry where cybersecurity may be a concern. 

“Although ISO 27001 certification is not mandatory at this time, MaxQ AI chose to pursue this higher standard because we understood the commercial benefits for our channel partners and for the healthcare sector as a whole,” Robert Mehler, MaxQ AI’s co-founder, COO and chief information security officer, said in a prepared statement. “Cybersecurity is a threat that goes far beyond lost revenue and expenses. An attack can have dire, potentially irreparable consequences for patient care and to the healthcare organization’s reputation.”

Earning this certification took a full year of preparation, with MaxQ AI’s quality management system team working to make sure each department was doing its part to help recognize and combat any potential security issues.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.